ZOCOR (Brand for SIMVASTATIN) SIMVASTATIN (SIM va sta tin) treats high cholesterol and reduces the risk of heart attack and stroke
It is supplied by Blu Pharmaceuticals
High concentrations of LDL cholesterol can lead to artery damage, potentially leading to cardiac complications and stroke
Simvastatin may
Simvastatin oral suspension is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: reduce the risk of total mortality by reducing
Constipation Nausea Muscle pain Severe muscle damage Liver damage Blood sugar changes Contacting your provider Bottom line References GoodRx Health
It
What does Simvastatin look like? 1 / 4 LL C03 Simvastatin Strength 20 mg Imprint LL C03 Color Tan Shape Oval View details 1 / 8 A 02 Simvastatin Strength 20 mg Imprint A 02
In many cases, these interactions can increase the risk of muscle pain and damage
Simvastatin is also known by its brand name, Zocor
yellow eyes or skin
It is not known if this drug is excreted in human milk; a small amount of another statin drug has been observed in human milk
Your doctor may adjust your dose as needed
Your simvastatin dosage will usually depend on why you’re taking it, your treatment goals, and other medications that you take
Over-exposure to statins can result in an increased risk of adverse effects
Simvastatin is used together with a proper diet to treat high cholesterol and triglyceride (fat) levels in the blood
It’s also taken to prevent heart disease, including heart attacks and strokes
32% of reviewers reported a positive effect, while 49% reported a negative effect
yellowing of the skin or eyes
Simvastatin may also be used to prevent certain types of heart problems in patients with risk factors for heart problems
Each is available as a generic product, as well
At doses 40 mg to 80 mg, pravastatin can lower your cholesterol levels by almost 50%
Pill with imprint S 5 is Red, Oval and has been identified as Simvastatin 20 mg
9 million deaths in the coronavirus disease 2019 (Covid-19) pandemic, and Simvastatin 10 mg tablets can be sold to the public to reduce risk of first coronary event in individuals at moderate risk of coronary heart disease (approx